Page last updated: 2024-09-03

sk&f 89748 and sdz nvi-085

sk&f 89748 has been researched along with sdz nvi-085 in 1 studies

Compound Research Comparison

Studies
(sk&f 89748)
Trials
(sk&f 89748)
Recent Studies (post-2010)
(sk&f 89748)
Studies
(sdz nvi-085)
Trials
(sdz nvi-085)
Recent Studies (post-2010) (sdz nvi-085)
16001010

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Apaydin, S; Saxena, PR; Van der Graaf, PH1

Other Studies

1 other study(ies) available for sk&f 89748 and sdz nvi-085

ArticleYear
The alpha 1-adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta.
    European journal of pharmacology, 1995, Dec-20, Volume: 287, Issue:3

    Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Aorta, Thoracic; Binding, Competitive; Bridged-Ring Compounds; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oxazines; Rats; Rats, Wistar; Serotonin; Tetrahydronaphthalenes

1995